| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| Do | b1BANK: Business First Bancshares, Inc. Completes $85.0 Million Private Placement of Subordinated Notes | ||
| Do | KBR, Inc.: KBR's Mission Technology Solutions Supports NASA's Artemis II Mission as Astronauts Embark on Historic Return to the Moon | ||
| Do | Alerus Financial Corporation to Announce First Quarter Financial Results on Wednesday, April 29 | ||
| Do | California Water Service Group Earns Spot on Newsweek's "Most Trustworthy Companies in America" List for Fourth Time | ||
| Do | Exodus to Host Inaugural Shareholder Day, The Exodus Summit on May 1 in Omaha | ||
| Do | Applied Optoelectronics, Inc.: AOI Receives New Upsized Order for 800G Data Center Transceivers from Major Hyperscale Customer | ||
| Do | PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share | ||
| Do | PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share | ||
| Do | Equillium, Inc.: Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| Do | ACM Research, Inc.: ACM Research Introduces ACM Planetary Family Product Portfolio Structure | ||
| Do | Safe Bulkers, Inc. Declares Quarterly Dividend on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares; 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares | ||
| Do | Terns Pharmaceuticals, Inc.: Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) | ||
| Do | Relay Therapeutics, Inc.: Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026 | ||
| Do | Ethos Technologies Inc: Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026 | ||
| Do | Grocery Outlet Holding Corp. Adds Two New Independent Directors | ||
| Do | Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| Do | Fate Therapeutics, Inc.: Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) | ||
| Do | Encore Capital Group, Inc.: Encore Capital Group to Announce First Quarter 2026 Financial Results on May 6 | ||
| Do | Akebia Therapeutics, Inc.: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| Do | Credit Acceptance Corporation: Credit Acceptance Celebrates Being Named No. 18 on Fortune's 2026 100 Best Companies to Work For List | ||
| Do | FibroBiologics, Inc.: FibroBiologics Announces Closing of $3 Million Public Offering | ||
| Do | Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| Do | Nilörngruppen AB: Nilörngruppen publishes the Annual Report incl. the Sustainability Report for 2025 | ||
| Do | MediWound Ltd.: MediWound Reports BARDA Contract Award to Vericel for NexoBrid Valued at up to $197 Million |